Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. Its objective is to redefine the therapeutic and preventive paradigm of stroke. The company was founded by Guo Hui Wang, Kui Ding, and Jia Qi Hong on June 16, 2016 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company